Quarterly report pursuant to Section 13 or 15(d)

SEGMENT REPORTING (Tables)

v3.23.1
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table is a comparative summary of the Company’s net sales and segment loss by reportable segment for the periods presented:
Three Months Ended March 31,
  2023 2022
Segment Net Revenue:
Cannabinoid $ 1,222  $ 1,811 
Non-Cannabinoid 2,756  3,230 
Total Net Revenue 3,978  5,041 
 
Segment Profit (Loss):
Cannabinoid (2,315) (5,705)
Non-Cannabinoid 447  348 
Total Loss $ (1,868) $ (5,357)
 
Reconciliation:
Total Segment Loss (1,868) (5,357)
Unallocated corporate expenses (1,558) (3,535)
Non-cash share-based compensation (468) (500)
Depreciation and amortization (236) (327)
Loss from operations $ (4,130) $ (9,719)
 
Loss on debt extinguishment, net   2,263 
Loss (gain) on remeasurement of warrant liability 44  (490)
Foreign exchange (gain) loss (45) 211 
Interest (income) expense and amortization of debt issuance cost (17) 2,109 
Other expense (income), net 39  (51)
Loss from operations before income taxes and equity investment loss $ (4,151) $ (13,761)
Disaggregation of Revenue
The following table disaggregates the Company’s revenue by channel for the periods presented:

Three Months Ended March 31,
2023 2022
Mass retail $ 2,524  $ 2,814 
Distributors 1,262  1,658 
Specialty, health and other retail 161  392 
E-commerce 31  177 
Total $ 3,978  $ 5,041 
The following table represents the Company's revenues attributed to countries based on location of customer:
Three Months Ended March 31,
2023 2022
United States $ 2,756  $ 3,233 
Brazil 887  643 
Israel 250  638 
Australia (a)
36  368 
Other 49  159 
 Total $ 3,978  $ 5,041 
(a) During the quarter, we made additional sales of Portuguese flowers of approximately $300 to Australia, recognized as part of our discontinued operation. See Note 19 for further information.
Schedule of Revenue by Major Customers by Reporting Segments
Customers with an accounts receivable balance of 10% or greater of total accounts receivable and customers with net revenue of 10% or greater of total revenues are presented below for the periods indicated:

Percentage of Revenues Percentage of Accounts Receivable
Three Months Ended March 31, 2023 March 31, December 31,
2023 2022 2023 2022
Customer A (a)
15% 11% 12% 18%
Customer B (b)
* 13% * 13%
Customer C (b)
* * * 15%
Customer D (b)
* 13% * *
Customer E (b)
20% * 28% *
Customer F (b)
* * * 10%
* denotes less than 10%

(a) net sales attributed are reflected in the non-cannabinoid segments
(b) net sales attributed are reflected in the cannabinoid segments
Long-lived Assets by Geographic Areas
The following table disaggregates the Company’s long-lived assets, by segment for the periods presented:
March 31,
2023
December 31,
2022
Long-lived assets
   
Cannabinoid $ 14,861  $ 15,308 
Non-Cannabinoid 130  155 
Total $ 14,991  $ 15,463